Houston—Juliana Garaizar, managing director of the Houston Angel Network, is used to dealing with big egos and strong personalities in both the investing and tech worlds.
“If it’s up to me, I try to work as little as possible with... Read more »
Executive Partner, Sofinnova Ventures
Founder and Managing Director of DEV
Founder and CEO of Brooks Bell Inc.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
[Updated 5/25/17, 12:44 p.m. See below.] Constellation Pharmaceuticals, a Cambridge, MA-based biotech that up until 2015 had a sprawling alliance with Genentech, has made sweeping changes this morning. The firm has replaced its president and CEO, will transition its... Read more »
An ambitious plan to recruit 1 million U.S. volunteers and amass a treasure trove of their health information will start next week with a “beta test” that health officials hope to eventually expand nationwide.
National Institutes of Health director Francis Collins... Read more »
Microsoft is acquiring cybersecurity startup Hexadite for $100 million, according to a report by Israeli publication Calcalist.
Xconomy has not yet confirmed the report. A Microsoft spokesperson said the company has “nothing to share at this time.” Hexadite CEO and co-founder... Read more »
Zesty.io, a San Diego Web development firm, has raised $1.3 million in seed funding to spin out its consulting business, and focus instead on providing its core Web content management technology as a subscription-based software-as-a-service.
CEO Randy Apuzzo said Zesty changed... Read more »
Interactions, a Franklin, MA-based company using artificial intelligence technologies to power virtual assistants for enterprise customers, today announced it has acquired Digital Roots, a metro Detroit startup focused on AI-based customer engagement on social media. The specific terms of... Read more »
Gener8tor, a Wisconsin-based group that runs training programs for early-stage companies and invests in them, is considering bringing those programs to Indianapolis.
The organization is still finalizing its decision about whether to expand into the Hoosier State. But if Gener8tor... Read more »
Amgen revealed late Sunday that safety problems have emerged in clinical testing of its closely watched osteoporosis drug, romosozumab (Evenity)—a development that will at minimum delay the drug’s path to approval, if not keep it off the market altogether.
The Thousand... Read more »
Founding Director, Massachusetts Technology Transfer Center
Chairman of the NY Tech Meetup
Founder and Managing Partner, Frazier Healthcare Ventures
Partner at New Enterprise Associates
Vice President for Research at UT Health Science Center at San Antonio